Acute Migraine

RESEARCH STUDY CURRENTLY ENROLLING
call 757-591-8100

Acute Migraine

Males and Females 18 years and older

The trial is being conducted to see how effective the medication zavegepant is in the possible treatment of migraines.

Eligibility
  • Medical Diagnosis of migraines for at least 1 year.
  • Migraine attacks, on average, lasting about 4 – 72 hours if untreated
  • Must be able to distinguish migraine attacks from tension/cluster headaches.
  • Must use 2 acceptable methods of contraception to avoid pregnancy throughout the study
Trial Duration

The trial will last up to 11 weeks involving 3 visits to our office

Compensation

You will be paid via check at the completion of the trial.

Apply for this Study & take the first step towards better care for yourself today.

  • MM slash DD slash YYYY